Trials / Completed
CompletedNCT01005056
Post-marketing, Observational Study to Confirm the Safety and Efficacy of MARVELON (Study P06083)
Drug Use Investigation of MARVELON
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,838 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of Marvelon® in the prevention of pregnancy. Post-marketing surveys are not considered applicable clinical trials and thus the results of this survey will not be posted at its conclusion. The results will be submitted to public health officials as required by applicable national and international laws.
Detailed description
Women with willingness to prevent pregnancy, who do not meet any of the contraindications, and who will take Marvelon® in compliance with the approved dosage and administration method will be enrolled.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ethinylestradiol + Desogestrel | All participants receive Marvelon® according to the approved dosage and administration method. |
Timeline
- Start date
- 2005-05-01
- Primary completion
- 2009-03-01
- Completion
- 2009-03-01
- First posted
- 2009-10-30
- Last updated
- 2022-02-04
Source: ClinicalTrials.gov record NCT01005056. Inclusion in this directory is not an endorsement.